Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: Results of ten years of prospective surveillance

Arthritis and Rheumatism

Volumn 54, Issue 6, 2006, Pages 1974-1981

  Hirschl, Mirko ^a   Hirschl, Katharina ^a   Lenz, Matthias ^a   Katzenschlager, Reinhold ^a   Hutter, Hans Peter ^b   Kundi, Michael ^b  

^a HANUSCH HOSPITAL   (Austria)

^b Medical University of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAYNAUD PHENOMENON; RISK FACTOR; SCREENING;

ADULT; ANTIBODIES, ANTINUCLEAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RAYNAUD DISEASE;

EID: 33745042376     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21912     Document Type: Article

References (33)

1. Raynaud M. Local asphyxia and symmetrical gangrene of the extremities. Paris: L. Leclerc; 1862.
2. Block JA, Sequeira W. Raynaud's phenomenon [review]. Lancet 2001;357:2042-8.
3. Flavahan NA, Flavahan S, Mitra S, Chotani MA. The vasculopathy of Raynaud's phenomenon and scleroderma [review]. Rheum Dis Clin North Am 2003;29:275-91.
4. Fraenkel L. Rayaud's phenomenon: epidemiology and risk factors [review]. Curr Rheumatol Rep 2002;4:123-8.
5. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998;158:595-600.
6. Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G. Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 1998;17:195-201.
7. De Angelis R, Del Medico P, Blasetti P, Cervini C. Raynaud's phenomenon: clinical spectrum of 118 patients. Clin Rheumatol 2003;22:279-84.
8. Grassi W, De Angelis R, Lapadula G, Leardini G, Scarpa R. Clinical diagnosis found in patients with Raynaud's phenomenon: a multicentre study. Rheumatol Int 1998;18:17-20.
9. Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988;47:634-41.
10. Kallenberg CG. Raynaud's phenomenon as an early sign of connective tissue diseases [review]. Vasa Suppl 1992;34:25-8.
11. Landry GJ, Edwards JM, McLafferty RB, Taylor LM Jr, Porter JM. Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort. J Vasc Surg 1996;23:76-85.
12. Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G. The evolution of Raynaud's phenomenon: a long-term prospective study. J Rheumatol 1995;22:2226-32.
13. Priollet P, Vayssairat M, Housset E. How to classify Raynaud's phenomenon: long-term follow-up study of 73 cases [published erratum appears in Am J Med 1987;83:A11]. Am J Med 1987;83:494-8.
14. Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO, et al. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 1999;26:816-25.
15. Ziegler S, Brunner M, Eigenbauer E, Minar E. Long-term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12-year retrospective patient analysis. Scand J Rheumatol 2003;32:343-7.
16. Meli M, Gitzelmann G, Koppensteiner R, Amann-Vesti BR. Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon. Clin Rheumatol 2005;25:153-8.
17. Belch JF. Raynaud's phenomenon [review]. Curr Opin Rheumatol 1990;2:937-41.
18. Isenberg DA, Black C. ABC of Rheumatology: Raynaud's phenomenon, scleroderma, and overlap syndromes [review]. BMJ 1995;310:795-8.
19. Hirschl M, Kundi M. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology. J Rheumatol 1996;23:302-9.
20. Maricq HR. Wide-field capillary microscopy. Arthritis Rheum 1981;24:1159-65.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
23. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
24. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
25. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 1989;16:328-34.
26. Suter LG, Murabito JM, Felson DT, Fraenkel L. The incidence and natural history of Raynaud's phenomenon in the community. Arthritis Rheum 2005;52:1259-63.
27. Palmer KT, Griffin MJ, Syddall H, Pannett B, Cooper C, Coggon D. Prevalence of Raynaud's phenomenon in Great Britain and its relation to hand transmitted vibration: a national postal survey. Occup Environ Med 2000;57:448-52.
28. Gifford RW Jr, Hines EA Jr. Raynaud's disease among women and girls. Circulation 1957;16:1012-21.
29. Pistorius MA, Planchon B. Incidence of thoracic outlet syndrome on the epidemiology and clinical presentation of apparently primary Raynaud's phenomenon: a prospective study in 570 patients. Int Angiol 1995;14:60-4.
30. Planchon B, Pistorius MA, Beurrier P, De Faucal P. Primary Raynaud's phenomenon: age of onset and pathogenesis in a prospective study of 424 patients. Angiology 1994;45:677-86.
31. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon: an analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986;13:556-63.
32. Costenbader KH, Karlson EW. Cigarette smoking and systemic lupus erythematosus: a smoking gun? [review]. Autoimmunity 2005;38:541-7.
33. Klareskog L, Alfredsson L, Rantapaa-Dahlqvist S, Berglin E, Stolt P, Padyukov L. What precedes development of rheumatoid arthritis? [review]. Ann Rheum Dis 2004;63 Suppl 2:ii28-ii31.